New insights into the thermal degradation behavior of Hydroxypropyl-beta-cyclodextrin inclusion complexes containing carvacrol essential oil via thermogravimetric analysis

New insights into the influence of encapsulation materials on the feasibility of ultrasonic-assisted encapsulation of Mosla chinensis essential oil

“…The first weight loss phase is attributed to the evaporation of water molecules inside the CDs cavity near 100 °C; the second weight loss ranges between 300 and 400 °C, which is related to the degradation of CDs macromolecules [43] . EO shows degradation peaks generally in the range of 30–200 °C [38] , [56] . In Fig.…”

“…FWO model: The same conversion rate value α at different heating rates was picked, and a linear regression of T −1 with ln β was fitted [38] . According to the gradient of the line fitted to obtain the value of h at the corresponding conversion rate.…”

Fabrication and Characterization of β-Cyclodextrin/Mosla Chinensis Essential Oil Inclusion Complexes: Experimental Design and Molecular Modeling

“…β-CD, PM, and β-CD/EO IC with KBr at a ratio of 1:100 were ground and mixed thoroughly together, and two drops of EO were attached to the surface of the KBr tablet, in which the samples were tested at the wavenumber range of 400 ~4000 cm −1 and the scanning speed was 16 cm −1 /s. The FT-IR spectral data were recorded after the baseline had been smoothed and corrected by the built-in software [64].…”

“…In each case, about 5~10 mg of sample was heated from 30 to 700 • C under a 200 mL/min nitrogen atmosphere with a heating rate of 10 • C/min. The thermal behavior of samples was analyzed by thermogravimetry (TG) and derivative thermogravimetry (DTG) curves [64].…”

Effect of temperature on the structure and drug-release behaviour of inclusion complex of β-cyclodextrin with cyclophosphamide: a molecular dynamics study

“…Notably, the b-CD molecule containing seven glucopyranose units has desirable features, such as cavity diameter and volume that allow for inclusion of many types of drugs (B6.0-6.5 Å; and B262 Å 3 , respectively) and relatively low cost of production owing to advances in synthetic technology. 11 In the past decade, extensive research on b-CDs and b-CD-drug complexes has been conducted via computer simulations [12][13][14][15][16][17][18] and experiments 14,[18][19][20][21][22][23][24][25] with the goal of developing new DDSs. For instance, a recent experimental study on the inclusion complex of Sulfobutyl-b-CD and Celastrol demonstrated that the formation of the inclusion complex enhances Celastrols intestinal permeability and stability under physiological and biological conditions.…”